Dietary counseling based on artificial intelligence for patients with nonalcoholic fatty liver disease

doi:10.35712/aig.v3.i4.105

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5511)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

180

WORD

HTML

2246

Figures (1-5)

278

Tables (1-4)

313

Sum=3089

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

256

Download

1004

Sum=1260

Publishing Process of This Article

Item

Count

Browse

330

Download

832

Sum=1162

Oct 28, 2022 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

Artificial Intelligence in Gastroenterology

ISSN

2644-3236

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

Artif Intell Gastroenterol. Oct 28, 2022; 3(4): 105-116
Published online Oct 28, 2022. doi: 10.35712/aig.v3.i4.105

Table 1 Patients' characteristics (n = 29)

Male/Female	16/13
Age (yr)	56.4 ± 14.3
Body weight (kg)	74.1 ± 13.1
BMI (kg/m²)	28.4 ± 5.2
Metabolic diseases
Diabetes mellitus (Yes/No)	10/19
Dyslipidemia (Yes/No)	14/15
Concomitant drugs
SGLT2 inhibitor	2
DPP-4 inhibitor	3
Thiazolidinedione
GLP-1 agonist	1
Statin	7
Bezafibrate
Pemafibrate
EPA and DHA preparation	1
AST (U/L)	50.2 ± 33.4
ALT (U/L)	53.8 ± 39.0
GGT (U/L)	80.3 ± 84.3
T-B (mg/dL)	1.3 ± 0.9
Alb (mg/dL)	4.2 ± 0.6
eGFR (mL/min)	71.1 ± 11.5
HbA1c (%)	6.4 ± 0.8
T-cho (mg/dL)	191.3 ± 35.0
TG (mg/dL)	126.5 ± 57.8
WBC (10³/μL)	5.6 ± 1.5
Hb (g/dL)	14.5 ± 1.7
Plts (10⁴/μL)	17.7 ± 7.4

AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; GGT: γ-Glutamyltransferase; T-Bil: Total bilirubin; Alb: Albumin; eGFR: Estimated glomerular filtration rate; HbA1c: Glycated hemoglobin A1c; T-chol: Total cholesterol; TG: Triglycerides; WBC: White blood cells; Hb: Hemoglobin; Plts: Platelets.

Citation: Kusano Y, Funada K, Yamaguchi M, Sugawara M, Tamano M. Dietary counseling based on artificial intelligence for patients with nonalcoholic fatty liver disease. Artif Intell Gastroenterol 2022; 3(4): 105-116
URL: https://www.wjgnet.com/2644-3236/full/v3/i4/105.htm
DOI: https://dx.doi.org/10.35712/aig.v3.i4.105